Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Unraveling Alzheimer’s: Exploring the Gut Microbiota-Brain Axis as a New Frontier in Understanding

Version 1 : Received: 8 May 2024 / Approved: 9 May 2024 / Online: 9 May 2024 (16:47:28 CEST)

How to cite: Rashid, S. M.; Razak, R.; Tantra, A. K.; James, A. W.; Showkat, N.; Shehjar, F.; Jan, F.; Ahmad, S. B.; Khan, A.; Shah, Z. A. Unraveling Alzheimer’s: Exploring the Gut Microbiota-Brain Axis as a New Frontier in Understanding. Preprints 2024, 2024050615. https://doi.org/10.20944/preprints202405.0615.v1 Rashid, S. M.; Razak, R.; Tantra, A. K.; James, A. W.; Showkat, N.; Shehjar, F.; Jan, F.; Ahmad, S. B.; Khan, A.; Shah, Z. A. Unraveling Alzheimer’s: Exploring the Gut Microbiota-Brain Axis as a New Frontier in Understanding. Preprints 2024, 2024050615. https://doi.org/10.20944/preprints202405.0615.v1

Abstract

The gut microbiota (GM) communicates with the brain via biochemical signaling constituting the gut-brain axis, which significantly regulates the body's physiological processes. The GM dysbiosis can impact the digestive system and the functioning of the central nervous system (CNS) linked to the onset of neurodegenerative diseases. In this review, the scientific data compiled from diverse sources primarily emphasizes the neuropathological characteristics linked to the accumulation of modified insoluble proteins (such as β-Amyloid peptides and hyperphosphorylated tau proteins) in Alzheimer’s Disease (AD) and the potential impact of gut microbiota (GM) on AD susceptibility or resilience. The specific GM profile of human beings may serve as an essential tool for preventing or progressing neurodegenerative diseases like AD. This review focuses mainly on the effect of gut microfauna on the gut-brain axis in the onset and progression of AD. The GM produces various bioactive molecules that may serve as proinflammatory or anti-inflammatory signaling, contributing directly or indirectly to the repression or progression of neurodegenerative disorders by modulating the response of the brain axis. Human studies must focus on further understanding the gut-brain axis and venture to clarify microbiota-based therapeutic strategies for AD.

Keywords

Alzheimer’s Disease; Neurodegenerative disorders; β amyloid, tau protein; Gut microbiota brain axis

Subject

Biology and Life Sciences, Neuroscience and Neurology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.